Active	Status	Sponsor type	Region	Phase	Filter
2 Active 1 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « May » « 2025 » M T W T F S S 28 29 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1   - « May » « 2025 » M T W T F S S 28 29 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1   Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Sarpal, Deepak
NCT06562608: Anticholinergic Deprescription in Schizophrenia	Recruiting	4	105	US	Anticholinergic Deprescription, No Anticholinergic Deprescription	Deepak K. Sarpal, M.D., National Institute of Mental Health (NIMH)	Schizophrenia, Schizoaffective Disorder	12/28	06/29
NCT06003036: Accelerated Transcranial Magnetic Stimulation for People with Schizophrenia Treated with Clozapine	Recruiting	N/A	30	US	sham stimulation, transcranial magnetic stimulation	Deepak K. Sarpal, M.D., National Institute of Mental Health (NIMH)	Schizophrenia, Schizoaffective Disorder	06/25	09/25

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Sarpal, Deepak
NCT06562608: Anticholinergic Deprescription in Schizophrenia	Recruiting	4	105	US	Anticholinergic Deprescription, No Anticholinergic Deprescription	Deepak K. Sarpal, M.D., National Institute of Mental Health (NIMH)	Schizophrenia, Schizoaffective Disorder	12/28	06/29
NCT06003036: Accelerated Transcranial Magnetic Stimulation for People with Schizophrenia Treated with Clozapine	Recruiting	N/A	30	US	sham stimulation, transcranial magnetic stimulation	Deepak K. Sarpal, M.D., National Institute of Mental Health (NIMH)	Schizophrenia, Schizoaffective Disorder	06/25	09/25